Section 26B-3-134 - Coverage of exome sequence testing(1) As used in this section, "exome sequence testing" means a genomic technique for sequencing the genome of an individual for diagnostic purposes.(2) The Medicaid program shall reimburse for exome sequence testing:(a) for an enrollee who:(i) is younger than 21 years old; and(ii) who remains undiagnosed after exhausting all other appropriate diagnostic-related tests;(b) performed by a nationally recognized provider with significant experience in exome sequence testing;(c) that is medically necessary; and(d) at a rate set by the Medicaid program.Renumbered from § 26-18-25 and amended by Chapter 306, 2023 General Session ,§ 34, eff. 5/3/2023.Added by Chapter 320, 2019 General Session ,§ 1, eff. 5/14/2019.